Bovine Veterinarian editor John Maday, right, talks with Dr. Larry Hawkins, Senior Technical Service Veterinarian of Bayer HealthCare, about Zelnate at the 2015 AABP Annual Conference in New Orleans. Zelnate is a novel, non-antibiotic technology and first-of-its-kind immunostimulant that jumpstarts the animal’s own defense system to help fight infectious disease. It effectively mitigates bovine respiratory disease (BRD) due to Mannheimia haemolytica and reduces mortality. It is administered to cattle at high risk of respiratory disease to effectively reduce mortality and lung lesions, which may result in a decreased need for antibiotics.